Biopharma and Medtech Activity in Q3 2026

Biopharma and medtech activity in Q3 2026

Explore the latest biopharma and medtech dealmaking trends in J.P. Morgan’s reports, featuring data provided by DealForma, and download the reports for insights into licensing, M&A, and financing activity. View them here

All of this by stage, disease indication, modality, target…

+ 0 k
Licensing Deals
+ 0 k
M&A
+ 0 k
Other Deals
+ 0 k
Funding Rounds
+ 0 k
Company Profiles
+ 0 k
Drug Sales Figures